Publications by authors named "Jason Xenakis"

Claim this Profile
A
Adult, adolescent, and caregiver preferences for attributes of topical treatments for mild-to-moderate atopic dermatitis: a discrete-choice experiment.
Steven R Feldman, Jacob P Thyssen, Marco Boeri, Robert Gerber, Maureen P Neary, Jason Xenakis

J Dermatolog Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Peak Pruritus-Numerical Rating Scale in patients with chronic plaque psoriasis: results from a phase 2 study.
Zoe D Draelos, Andrew G Bushmakin, Pranab Ghosh, Jason Xenakis, Joseph C Cappelleri

Int J Dermatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Manifestations in Patients with Dermatomyositis, Are They Only Skin Deep?
Stephanie McKee, Jason Xenakis, Harriet Makin, Chris Marshall, Randall Winnette

Dermatol Ther (Heidelb)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis.
Stephanie McKee, Jason Xenakis, Harriet Makin, Chris Marshall, Randall Winnette

Dermatol Ther (Heidelb)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of topical brepocitinib for the treatment of mild-to-moderate atopic dermatitis: a phase IIb, randomized, double-blind, vehicle-controlled, dose-ranging and parallel-group study.
Megan N Landis, Mark Arya, Stacy Smith, Zoe Draelos, Lisa Usdan, Jason Xenakis

Br J Dermatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA.
Arash Mostaghimi, Jason Xenakis, Aster Meche, Timothy W Smith, David Gruben

Dermatol Ther (Heidelb)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib.
Eric L Simpson, Andreas Wollenberg, Robert Bissonnette, Jonathan I Silverberg, Jocelyne Papacharalambous, Jason Xenakis

Dermatitis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Perspectives of the Social, Emotional and Functional Impact of Alopecia Areata: A Systematic Literature Review.
Arash Mostaghimi, Lynne Napatalung, Vanja Sikirica, Randall Winnette, Jason Xenakis

Dermatol Ther (Heidelb)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laryngeal involvement in a patient with active postprimary tuberculosis: Case report of a rare extrapulmonary manifestation.
Brian Shim, Swachchhanda Songmen, Jason Xenakis, Joshua Sapire

Radiol Case Rep· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remote allergen exposure elicits eosinophil infiltration into allergen nonexposed mucosal organs and primes for allergic inflammation.
Courtney L Olbrich, Maytal Bivas-Benita, Jason J Xenakis, Samuel Maldonado, Evangeline Cornwell

Mucosal Immunol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs and Treatment Patterns Among Patients with Atopic Dermatitis Using Advanced Therapies in the United States: Analysis of a Retrospective Claims Database.
Lawrence F Eichenfield, Marco DiBonaventura, Jason Xenakis, Marie-Helene Lafeuille, Mei Sheng Duh

Dermatol Ther (Heidelb)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Technology and social media use by adult patients with intellectual and/or developmental disabilities.
Patricia A Patrick, Izel Obermeyer, Jason Xenakis, Doug Crocitto, David M O'Hara

Disabil Health J· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resident intestinal eosinophils constitutively express antigen presentation markers and include two phenotypically distinct subsets of eosinophils.
Jason J Xenakis, Emily D Howard, Kalmia M Smith, Courtney L Olbrich, Yanjun Huang

Immunology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experiences of People with Diabetes by Payer Type: An Analysis of the Roper Diabetes Data Set.
Susan S Garfield, Jason J Xenakis, Alex Bastian, Mary McBride

Diabetes Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCL11 elicits secretion of RNases from mouse eosinophils and their cell-free granules.
Revital Shamri, Rossana C N Melo, Kristen M Young, Maytal Bivas-Benita, Jason J Xenakis

FASEB J· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophils: offenders or general bystanders in allergic airway disease and pulmonary immunity?
Praveen Akuthota, Jason J Xenakis, Peter F Weller

J Innate Immun· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophils in innate immunity: an evolving story.
Revital Shamri, Jason J Xenakis, Lisa A Spencer

Cell Tissue Res· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis